🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Evaluation by Clinical and Hand Ultrasound in Carpal Tunnel Syndrome

Recruitingn/aAges 18 Years - anyAllUniversity of Sao Paulo General Hospital
NCT07134361 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Carpal Tunnel Syndrome (CTS) is a common condition where pressure on the median nerve in the wrist causes pain, numbness, and weakness in the hand. Surgery to release the carpal tunnel is often performed to relieve these symptoms. This study will evaluate the changes in the median nerve after surgery and how these changes relate to symptom improvement. Investigators will use ultrasound imaging to measure the nerve size before and at three and six months after surgery. Patients will also complete questionnaires about their symptoms and hand function, and undergo tests to assess strength and sensation. The investigator's goal is to determine whether changes observed on ultrasound are associated with the rate of patient recovery. This may help doctors better monitor healing and improve care for people with CTS.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Clinical diagnosis of primary carpal tunnel syndrome (CTS), confirmed by characteristic symptoms, physical examination findings, and a cross-sectional area superior to 10 mm² in the ultrasonography baseline. * Indication for open carpal tunnel release as part of routine clinical care. Exclusion Criteria: * Secondary CTS due to inflammatory arthritis, prior wrist trauma, or space-occupying lesions. * History of previous carpal tunnel release in the affected hand. * Concomitant peripheral neuropathies (e.g., diabetic polyneuropathy) or cervical radiculopathy * Inability to undergo ultrasound assessment
💊

What it tests

  • Open Carpal Tunnel Release
📍

Where

1 site
Instituto de Ortopedia e Traumatologia do Hospital das Clínicas da FMUSP
São Paulo, Brazil
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy